APGE Apogee Therapeutics, Inc.
$135.07▲ +0.00%
Healthcare
Other
Volume 0
Avg Volume (10D) 1.43M
Key Metrics & Fundamentals
Market Cap
$10.22B
P/E Ratio
–
Div Yield
–%
52W Range
35.39 - 135.09
% vs 50 MA
0.67%
% vs 200 MA
46.31%
RSI-14
78.6
MACD Histogram
-0.3700
Beta (1Y vs SPY)
0.96
Free Cash Flow
-$71.38M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$79.43M
COGS
–
Operating Exp
$91.64M
Operating Income
-$91.64M
EBIT
-$91.64M
Pretax Income
-$85.78M
Net Income
-$85.85M
EPS (Diluted)
-1.14
Price & Volume History
Loading chart…
Recent News
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?
Insider Monkey · Sep 9, 2026 8:58 PM
Sector Update: Healthcare Stocks Edge Higher Late Afternoon
MT Newswires · Sep 3, 2026 7:46 PM
Sector Update: Healthcare Stocks Higher Thursday Afternoon
MT Newswires · Sep 3, 2026 5:49 PM
Sector Update: Healthcare
MT Newswires · Sep 3, 2026 5:09 PM
AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics
MT Newswires · Sep 3, 2026 1:13 PM
AbbVie Completes Acquisition of Apogee Therapeutics
PR Newswire · Sep 3, 2026 12:34 PM
Kymera's KT-621 Has 'Oral Dupixent' Potential, but Valuation Limits Upside, RBC Says
MT Newswires · Sep 2, 2026 2:59 PM
Is AbbVie (ABBV) Undervalued As It Expands Skyrizi In Crohns Disease?
Simply Wall St. · Aug 30, 2026 1:07 AM
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Aug 29, 2026 7:35 PM
AbbVie Defends Its Turf, But Leaves One Big Question Open
Trefis · Aug 14, 2026 9:22 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See APGE's money flow as a full page
Social Sentiment
No Reddit posts found for APGE.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.